These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Gender differences in the outcome of interventional cardiac procedures. Presbitero P, Carcagnì A. Ital Heart J; 2003 Aug; 4(8):522-7. PubMed ID: 14564977 [Abstract] [Full Text] [Related]
25. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB. Circulation; 2004 Sep 28; 110(13):1754-60. PubMed ID: 15381645 [Abstract] [Full Text] [Related]
26. Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90. Montague TJ, Wong RY, Burton JR, Bay KS, Catellier DJ, Teo KK. Can J Cardiol; 1992 Sep 28; 8(6):596-600. PubMed ID: 1354568 [Abstract] [Full Text] [Related]
31. Acute myocardial infarction in Alberta: temporal changes in outcomes, 1994 to 1999. Quan H, Cujec B, Jin Y, Johnson D. Can J Cardiol; 2004 Feb 28; 20(2):213-9. PubMed ID: 15010746 [Abstract] [Full Text] [Related]
33. Regional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantage. Krumholz HM, Chen J, Rathore SS, Wang Y, Radford MJ. Am Heart J; 2003 Aug 28; 146(2):242-9. PubMed ID: 12891191 [Abstract] [Full Text] [Related]
35. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry. Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, Yamaguchi J, Ishii Y, Fujii SY, Nagashima M, Okada H, Koganei H, Koyanagi R, Tsurumi Y, Kimura H, Ogawa H, HIJAMI Investigators. Am Heart J; 2005 Sep 28; 150(3):411-8. PubMed ID: 16169317 [Abstract] [Full Text] [Related]
37. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study. Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, Fujita T, Tsutani K, Sakuma A, Japanese Acute Myocardial Infarction Prospective study group. Am Heart J; 2004 Aug 28; 148(2):e8. PubMed ID: 15309011 [Abstract] [Full Text] [Related]
38. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, Luepker RV. N Engl J Med; 1996 Apr 04; 334(14):884-90. PubMed ID: 8596571 [Abstract] [Full Text] [Related]
39. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy. Kaul P, Armstrong PW, Fu Y, Knight JD, Clapp-Channing NE, Sutherland W, Granger CB, Mark DB, GUSTO-IIb investigators. Can J Cardiol; 2004 Jun 04; 20(8):760-6. PubMed ID: 15229756 [Abstract] [Full Text] [Related]